Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

23andMe said Monday it will lay off more than 200 employees, about 40% of its staff, and restructure the company amid its financial challenges. The genetic testing firm will discontinue the ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

The alliance positions GE Healthcare to distribute Radnet software designed to help mammography centers view images, ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

On Wednesday, Republican candidate and former president Donald Trump was elected to the nation’s highest office for the ...

Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...

CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing ...